Pizzuti, L., Marchetti, P., Natoli, C., Gamucci, T., Santini, D., Scinto, A. F., . . . Vici, P. (2017). Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study. Sci Rep.
Chicago-stil citatPizzuti, Laura, et al. "Fasting Glucose and Body Mass Index As Predictors of Activity in Breast Cancer Patients Treated With Everolimus-exemestane: The EverExt Study." Sci Rep 2017.
MLA-referensPizzuti, Laura, et al. "Fasting Glucose and Body Mass Index As Predictors of Activity in Breast Cancer Patients Treated With Everolimus-exemestane: The EverExt Study." Sci Rep 2017.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.